We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Health . Education . Research . Foundation
Internationally acknowledged researcher in cancer care Professor Sandie McCarthy has been jointly appointed as Professor of Clinical Nursing Research for The University of Queensland’s School of Nursing, Midwifery and Social Work and Mater.
In this inaugural role Professor McCarthy will provide strategic leadership, bringing together the clinical needs and research priorities of UQ and Mater.
“My vision is to harness the capabilities of the Mater and UQ nursing workforces to make our joint venture an internationally recognised centre for meaningful nursing inquiry,” Professor McCarthy said.
“My experience has been that clinical credibility, the capacity to network and willingness to engage in research and education alongside nursing clinicians is the way to do this.
“UQ and Mater jointly have an impressive clinical research footprint in Brisbane.
“This is an exciting position as it can leverage the networks, resources and knowledge within that footprint to promote nursing, and interdisciplinary research, even further on the national and international stage.”
Currently University of Auckland’s Head of the School of Nursing, Professor McCarthy is a dual-registered nurse in Australia and New Zealand, and a credentialed cancer nurse in Queensland.
Professor McCarthy has significant competitive grant success and is highly skilled in translating research findings into practice with positive outcomes for patients and their families.
“My clinical area of practice is cancer nursing, specialising in chemotherapy,” Professor McCarthy said.
“My personal research program focuses on the prevention and management of the short- and long-term toxicities of cancer treatments, particularly in women and older adults.”
Professor McCarthy will start on 29 July 2019.
07 3163 1524
07 3163 6142
As Touch Football Australia’s health partner Mater provided expert review and endorsement of their return-to-play protocols to help participants return safely.
Mater University of Queensland Researchers have achieved publication in the highly-ranked journal, Clinical and Translational Immunology detailing their work on a new ...
Mater continues to work as part of the broader health network in support of Public Health efforts to contain, treat and manage COVID-19.
The team at Mater Pathology’s Microbiology Laboratory are making moves to see greater automation and advanced technology make a difference to the speed at which ...